Skip to main content

Table 4 Prevalence of use of different antihypertensive drug classes in patients below and above the high cardiovascular risk VAI cutoff value

From: Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy

  β-blockers ACEIs ARBs CCBs Diuretics α1 adrenergic blockers
Whole population (n = 129) 45 (34.9) 39 (30.2) 55 (42.9) 25 (19.4) 60 (46.9) 7 (5.4)
 VAI class 0 (n = 70) 25 (35.7) 25 (35.7) 24 (34.3)* 10 (14.3) 33 (47.1) 4 (5.7)
 VAI class I (n = 59) 20 (33.9) 14 (23.7) 31 (52.5) 15 (25.4) 27 (45.8) 3 (5.1)
Only antihypertensive (n = 104) 35 (33.7) 33 (31.7) 45 (43.3) 20 (18.3) 48 (46.2) 4 (3.7)
 VAI class 0 (n = 60) 18 (30.0) 21 (35.0) 22 (36.7) 9 (15) 29 (48.3) 2 (3.3)
 VAI class I (n = 44) 17 (38.6) 12 (27.3) 23 (52.3) 11 (25) 19 (43.2) 2 (4.5)
  1. Patients in VAI class 0 have values of VAI below the high cardiovascular risk cutoff value whereas those with values above this cutoff are in VAI class I. The numbers in parentheses represent the percentage of the total of the respective group
  2. *p < 0.05 vs VAI class I